Impact of genotypic susceptibility score on cART outcomes during primary HIV infection
Academic Article
Publication Date:
2019
Short description:
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection / Giacomelli, A., Fabbiani, M., De Benedetto, I., Nozza, S., Foca, E., Celesia, B.M., Marchetti, G., Mussini, C., Antinori, A., D'Ettorre, G., Madeddu, G., Bandera, A., Muscatello, A., Rusconi, S.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 91:10(2019), pp. 1891-1895. [10.1002/jmv.25517]
abstract:
To assess the impact of genotypic susceptibility score (GSS) on combined antiretroviral therapy (cART) outcomes during primary HIV infection (PHI) we retrospectively enrolled patients with PHI diagnosed between 2008 and 2015 at 9/24 Italian Network ACuTe HIV InfectiON centers. One hundred-seventy-six patients were enrolled. Of these, 55 (32.9%) patients started with more than three drugs and 11 (7.2%) started with a GSS < 3. Regimen's GSS (per 1 point increase) (adjusted odds ratio [aOR], 4.82; 95% confidence interval [CI], 1.62-14.28; P =.005) and baseline HIV-RNA (per 1 log10 increase) (aOR, 2.02; 95% CI, 1.09-3.73; P =.025) resulted associated with early cART initiation. In conclusion, regimen's GSS resulted to be associated to the time to cART initiation during PHI.
Iris type:
1.1 Articolo in rivista
Keywords:
GSS; HIV; primary HIV
List of contributors:
Giacomelli, A.; Fabbiani, M.; De Benedetto, I.; Nozza, S.; Foca, E.; Celesia, B. M.; Marchetti, G.; Mussini, C.; Antinori, A.; D'Ettorre, G.; Madeddu, G.; Bandera, A.; Muscatello, A.; Rusconi, S.
Published in: